Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT
Genmab A/S Income Statement
Financials in DKK. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.93B | 6.44B | 5.54B | 5.4B | 4.14B | 4.68B | 4.74B | 4.2B | 2.85B | 5.23B | 4.09B | 3.16B | 2.12B | 2.62B | 2.31B | 1.97B | 1.58B |
Cost of Revenue | 42M | 337M | 273M | 190M | 185M | 126M | 100M | 21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 4.64B | 6.1B | 5.27B | 5.21B | 3.96B | 4.55B | 4.64B | 4.18B | 2.85B | 5.23B | 4.09B | 3.16B | 2.12B | 2.62B | 2.31B | 1.97B | 1.58B |
Operating Income | 188M | 2.16B | 2.1B | 1.82B | 801M | 1.67B | 1.69B | 1.47B | 417M | 2.67B | 681M | 1.25B | 514M | 809M | 890M | 787M | 532M |
Interest Income | 33M | 224M | 162M | 292M | 46M | 295M | 243M | 209M | 192M | 140M | 97M | 51M | 36M | 35M | 35M | 65M | 62M |
Pretax Income | 244M | 3.6B | 1.72B | 2.13B | 1.72B | 926M | 2.67B | 1.69B | 266M | 662M | 3.27B | 2.49B | 612M | 966M | 1.17B | 422M | 1.42B |
Net Income | 195M | 3.85B | 1.27B | 1.41B | 1.32B | 640M | 2.1B | 1.33B | 210M | 584M | 2.58B | 1.89B | 465M | 716M | 890M | 306M | 1.1B |
Selling & General & Admin | 126M | 1.25B | 865M | 894M | 857M | 934M | 839M | 848M | 676M | 921M | 670M | 633M | 452M | 512M | 306M | 264M | 201M |
Research & Development | 359M | 2.66B | 2.28B | 2.5B | 2.3B | 1.95B | 2.09B | 1.85B | 1.74B | 1.64B | 1.49B | 1.28B | 1.15B | 1.3B | 1.11B | 921M | 848M |
Other Expenses | n/a | 31M | 17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 485M | 3.94B | 3.17B | 3.4B | 3.16B | 2.88B | 2.93B | 2.7B | 2.42B | 2.56B | 2.16B | 1.92B | 1.6B | 1.81B | 1.42B | 1.19B | 1.05B |
Interest Expense | 5M | 54M | 18M | 19M | 4M | 6M | 8M | 7M | 6M | 5M | 6M | 6M | 4M | 3M | 4M | 430M | 3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.64B | 4.28B | 3.44B | 3.76B | 3.34B | 3.01B | 3.03B | 2.7B | 2.42B | 2.56B | 2.16B | 1.92B | 1.6B | 1.81B | 1.42B | 1.19B | 1.05B |
Income Tax Expense | 49M | -243M | 453M | 719M | 391M | 286M | 566M | 359M | 56M | 78M | 690M | 598M | 147M | 250M | 281M | 116M | 328M |
Shares Outstanding (Basic) | 637.25M | 641.56M | 648.85M | 648.85M | 653.03M | 653.06M | 653.07M | 652.4M | 654.21M | 652.85M | 652.84M | 655.01M | 657.34M | 654.06M | 653.93M | 653.85M | 653.94M |
Shares Outstanding (Diluted) | 639.34M | 641.54M | 648.85M | 648.85M | 656.59M | 657.87M | 658.73M | 658.42M | 658.31M | 660.7M | 659.18M | 659.8M | 659.57M | 661.42M | 660.73M | 659.48M | 659.84M |
EPS (Basic) | 0.31 | 5.99 | 1.95 | 2.17 | 2.03 | 0.98 | 3.26 | 2.08 | 0.32 | 0.90 | 3.96 | 2.89 | 0.71 | 1.10 | 1.36 | 0.47 | 1.68 |
EPS (Diluted) | 0.31 | 5.99 | 1.95 | 2.17 | 2.02 | 0.97 | 3.23 | 2.06 | 0.32 | 0.88 | 3.92 | 2.87 | 0.71 | 1.08 | 1.35 | 0.46 | 1.66 |
EBITDA | 265M | 2.35B | 1.85B | 2.15B | 861M | 932M | 1.8B | 1.72B | 471M | 667M | 3.28B | 1.31B | 616M | 969M | 1.18B | 844.5M | 1.43B |
EBIT | 249M | 2.27B | 1.74B | 2.15B | 801.87M | 932M | 2.68B | 1.72B | 272M | 667M | 3.28B | 2.5B | 616M | 969M | 1.18B | 787M | 1.43B |
Depreciation & Amortization | 16M | 115M | 85M | 69M | 60M | 60M | 85M | 81M | 54M | 54M | 62M | 62M | 62M | 62M | 57.5M | 57.5M | 57.5M |